Borrelia burgdorferi erpT expression in the arthropod vector and murine host
- 1 January 1999
- journal article
- research article
- Published by Wiley in Molecular Microbiology
- Vol. 31 (1), 281-290
- https://doi.org/10.1046/j.1365-2958.1999.01171.x
Abstract
The expression of a Borrelia burgdorferi gene, erpTwas investigated throughout the spirochaete life cycle in the arthropod vector and the murine host. Three phage clones from a B. burgdorferi DNA expression library synthesized a 30 kDa antigen that was recognized by antibodies in the sera of B. burgdorferi‐infected mice but not mice hyperimmunized with B. burgdorferi lysates. Differential antibody binding suggested that this protein was preferentially expressed in vivo. This antigen was designated ErpT, based upon 99.6% homology with the BBF01 sequence in the B. burgdorferi genome. ErpT was not detected on spirochaetes cultured in BSK II medium by indirect immunofluorescence or in B. burgdorferi lysates by immunoblotting, implying that ErpT is not readily produced in vitro. erpT mRNA was not discernible by Northern blot but was identified by RNA polymerase chain reaction in vitro, indicating that erpT is expressed at low levels by cultured spirochaetes. erpT expression was then investigated in the vector and mice because B. burgdorferi do not normally reside in culture medium. RNA polymerase chain reaction and immunofluorescence studies demonstrated that erpT was expressed by a small minority of B. burgdorferi (11/500, 2.2%) within unfed ticks and then repressed during engorgement. erpT mRNA or ErpT antibodies were first detected in B. burgdorferi‐infected mice at 4 weeks, suggesting that erpT was not expressed in the early stages of murine infection. Then, during persistent infection, RNA polymerase chain reaction showed that erpT was expressed by B. burgdorferi within the joints, heart and spleen, but not by spirochaetes in the skin. Immunization of mice with ErpT was antigenic but was not protective. These studies demonstrate that B. burgdorferi erpT is differentially expressed throughout the B. burgdorferi life cycle, in both the vector and the mammalian host, and is primarily expressed in extracutaneous sites during murine infection.Keywords
This publication has 49 references indexed in Scilit:
- Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host.Journal of Clinical Investigation, 1997
- Effect of anti-interleukin 12 treatment on murine lyme borreliosis.Journal of Clinical Investigation, 1996
- Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.The Journal of Experimental Medicine, 1996
- Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease.The Journal of Experimental Medicine, 1996
- Evidence for in vivo but not in vitro expression of a Borrelia burgdorferi outer surface protein F (OspF) homologueMolecular Microbiology, 1995
- Sera from Patients with Chronic Lyme Disease Protect Mice from Lyme BorreliosisThe Journal of Infectious Diseases, 1994
- Constructing polycompetitor cDNAs for quantitative PCRJournal of Immunological Methods, 1993
- Western Blotting in the Serodiagnosis of Lyme DiseaseThe Journal of Infectious Diseases, 1993
- Serologic Diagnosis of Lyme Disease using Recombinant Outer Surface Proteins A and Band FlagellinThe Journal of Infectious Diseases, 1992
- Lyme DiseaseNew England Journal of Medicine, 1989